PVM
Palogic Value Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.55M | Buy |
33,415
+125
| +0.4% | +$5.79K | 0.63% | 45 |
|
|
2025
Q1 | $2.03M | Buy |
33,290
+1,508
| +5% | +$92K | 0.88% | 38 |
|
|
2024
Q4 | $1.8M | Buy |
31,782
+128
| +0.4% | +$7.24K | 0.68% | 45 |
|
|
2024
Q3 | $1.64M | Buy |
31,654
+453
| +1% | +$23.4K | 0.56% | 49 |
|
|
2024
Q2 | $1.3M | Buy |
31,201
+284
| +0.9% | +$11.8K | 0.55% | 60 |
|
|
2024
Q1 | $1.68M | Buy |
30,917
+573
| +2% | +$31.1K | 0.73% | 50 |
|
|
2023
Q4 | $1.56M | Buy |
30,344
+706
| +2% | +$36.2K | 0.69% | 50 |
|
|
2023
Q3 | $1.72M | Buy |
29,638
+210
| +0.7% | +$12.2K | 0.82% | 43 |
|
|
2023
Q2 | $1.88M | Buy |
29,428
+61
| +0.2% | +$3.9K | 0.88% | 42 |
|
|
2023
Q1 | $2.04M | Buy |
29,367
+515
| +2% | +$35.7K | 1% | 31 |
|
|
2022
Q4 | $2.08M | Buy |
+28,852
| New | +$2.08M | 1.08% | 25 |
|